Transgene Pink Sheet Forecast - 4 Period Moving Average
| TRGNF Stock | USD 1.59 0.00 0.00% |
The 4 Period Moving Average forecasted value of Transgene SA on the next trading day is expected to be 1.59 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Transgene Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Transgene's historical fundamentals, such as revenue growth or operating cash flow patterns.
Transgene |
Transgene 4 Period Moving Average Price Forecast For the 23rd of November
Given 90 days horizon, the 4 Period Moving Average forecasted value of Transgene SA on the next trading day is expected to be 1.59 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Transgene Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Transgene's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Transgene Pink Sheet Forecast Pattern
| Backtest Transgene | Transgene Price Prediction | Buy or Sell Advice |
Transgene Forecasted Value
In the context of forecasting Transgene's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Transgene's downside and upside margins for the forecasting period are 1.59 and 1.59, respectively. We have considered Transgene's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Transgene pink sheet data series using in forecasting. Note that when a statistical model is used to represent Transgene pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Transgene
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Transgene SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Transgene
For every potential investor in Transgene, whether a beginner or expert, Transgene's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Transgene Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Transgene. Basic forecasting techniques help filter out the noise by identifying Transgene's price trends.Transgene Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Transgene pink sheet to make a market-neutral strategy. Peer analysis of Transgene could also be used in its relative valuation, which is a method of valuing Transgene by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Transgene SA Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Transgene's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Transgene's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Transgene Market Strength Events
Market strength indicators help investors to evaluate how Transgene pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Transgene shares will generate the highest return on investment. By undertsting and applying Transgene pink sheet market strength indicators, traders can identify Transgene SA entry and exit signals to maximize returns.
Currently Active Assets on Macroaxis
Other Information on Investing in Transgene Pink Sheet
Transgene financial ratios help investors to determine whether Transgene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.